Background illustration for clinical trials search

Paid Clinical Trials Salem

Discover 951 paid clinical trials in Salem, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative Study

for
Mycobacterium Avium Complex Pulmonary Disease
Location: Portland OR, Calgary
Sponsor: Radboud University Medical Center

Sex: All

Age: 18+

Code: NCT05906316

Recruiting
Active & Responsive

Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination

for
Yellow Fever, Immunization; Infection
Location: Portland OR
Sponsor: Oregon Health and Science University

Sex: All

Age: 20 - 49

Code: NCT05859490

Phase1, Phase2, Recruiting
Active & Responsive

Comparative Effectiveness of Cryoablation Versus Steroid and Lidocaine Alone for Treatment of Morton's Neuroma

for
Morton Neuroma
Location: Portland OR
Sponsor: Oregon Health and Science University

Sex: All

Age: 18 - 70+

Code: NCT05501262

Recruiting
Active & Responsive

Comprehensive HHT Outcomes Registry of the United States (CHORUS)

for
Hereditary Hemorrhagic Telangiectasia,
Location: Portland OR, San Francisco CA, Salt Lake City UT,
Sponsor: Cure HHT

Sex: All

Age: 0+

Code: NCT06259292

Recruiting
Active & Responsive

BBD Longitudinal Study of Osteogenesis Imperfecta

for
Osteogenesis Imperfecta
Location: Portland OR, Los Angeles CA, Phoenix AZ, Omaha NE,
Sponsor: Baylor College of Medicine

Sex: All

Age: 0+

Code: NCT02432625

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

for
Mesial Temporal Lobe Epilepsy
Location: Portland OR, Seattle WA, Sacramento CA,
Sponsor: Neurona Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT05135091

Phase3, Recruiting
Active & Responsive

ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis

for
X-linked Retinoschisis
Location: Portland OR, San Francisco CA, Salt Lake City UT,
Sponsor: Atsena Therapeutics Inc.

Sex: All

Age: 6+

Code: NCT05878860

Phase3, Recruiting
Active & Responsive

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

for
Immune Thrombocytopenic Purpura (ITP)
Location: Portland OR, Boston MA
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06948318

Phase3, Recruiting
Active & Responsive

FIH Study to Evaluate Safety, Tolerability, PK, PD & Preliminary Efficacy of AT03-65 With Advanced Solid Tumors

for
Solid Tumor
Location: Portland OR
Sponsor: Axcynsis Therapeutics Pte Ltd

Sex: All

Age: 18+

Code: NCT06809114

Phase1, Recruiting
Active & Responsive

EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)

for
PIK3CA-related Overgrowth Spectrum (PROS)
Location: Portland OR, Seattle WA, St Louis MO, Houston TX,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 2 - 70+

Code: NCT06997588

Phase2, Recruiting
Active & Responsive

AMEND TS Early Feasibility Study

for
Symptomatic Functional MR 3 or Greater
Location: Portland OR, Phoenix AZ, San Antonio TX, Houston TX,
Sponsor: Valcare Medical Ltd.

Sex: All

Age: 21+

Code: NCT06951672

Recruiting
Active & Responsive

Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

for
AML With Gene Mutations
Location: Portland OR, San Francisco CA, Los Angeles CA,
Sponsor: Lomond Therapeutics Holdings, Inc.

Sex: All

Age: 18+

Code: NCT06366789

Phase1, Recruiting
Active & Responsive

A Study of JNT-517 in Participants With Phenylketonuria (PKU)

for
Phenylketonuria
Location: Portland OR, Calgary, Salt Lake City UT, Los Angeles CA,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Sex: All

Age: 18+

Code: NCT06971731

Phase3, Recruiting
Active & Responsive

Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection

for
Viral Pneumonia
Location: Portland OR, Idaho Falls ID, Torrance CA, Rochester MN,
Sponsor: Synairgen Research Ltd.

Sex: All

Age: 18+

Code: NCT06999603

Phase2, Recruiting
Active & Responsive

Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis

for
PARKINSON DISEASE (Disorder), Parkinson,
Location: Portland OR
Sponsor: CND Life Sciences

Sex: All

Age: 40 - 70+

Code: NCT07204652

Recruiting
Active & Responsive

Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)

for
Optic Neuritis, Myelitis, Myelitis, Transverse
Location: Portland OR, Seattle WA, Sacramento CA,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07100990

Phase3, Recruiting
Active & Responsive

Clinical Course Of Disease In Participants With FA-CM

for
Friedreich Ataxia, Cardiomyopathy
Location: Portland OR, La Jolla CA, Rochester MN, St Louis MO,
Sponsor: Lexeo Therapeutics

Sex: All

Age: 6+

Code: NCT06865482

Recruiting
Active & Responsive

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

for
Lung Cancer Diagnosis
Location: Portland OR, Reno NV, Los Angeles CA, Houston TX,
Sponsor: Freenome Holdings Inc.

Sex: All

Age: 50+

Code: NCT06122077

Recruiting
Active & Responsive

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: Portland OR, Seattle WA, San Francisco CA, Palo Alto CA,
Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT05303519

Phase3, Recruiting
Active & Responsive

A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

for
Dravet Syndrome
Location: Portland OR, San Francisco CA, Salt Lake City UT,
Sponsor: Stoke Therapeutics, Inc

Sex: All

Age: 2 - 17

Code: NCT06872125

Phase3, Recruiting